Get the Stockscreener App
6.27
3.69%
-0.24
After Hours:
6.13
-0.14
-2.23%
Aclarion Inc stock is traded at $6.27, with a volume of 317.10K.
It is down -3.69% in the last 24 hours and up +3,584% over the past month.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The Company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.
See More
Previous Close:
$6.51
Open:
$6.55
24h Volume:
317.10K
Relative Volume:
0.01
Market Cap:
$6.37M
Revenue:
$49,300
Net Income/Loss:
$-6.27M
P/E Ratio:
-0.6898
EPS:
-9.09
Net Cash Flow:
$-5.38M
1W Performance:
-25.36%
1M Performance:
+3,584%
6M Performance:
+2,100%
1Y Performance:
+210.40%
1-Day Range:
$6.24
$6.98
1-Week Range:
$6.10
$8.77
52-Week Range:
$0.0275
$20.84
Aclarion Inc Stock (ACON) Company Profile
Name
Aclarion Inc
Sector
Industry
Phone
833 275 2266
Address
8181 ARISTA PLACE, BROOMFIELD
Compare ACON with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ACON
Aclarion Inc
|
6.27 | 6.37M | 49,300 | -6.27M | -5.38M | -9.09 |
|
VEEV
Veeva Systems Inc
|
239.43 | 38.87B | 2.66B | 665.91M | 1.08B | 4.05 |
|
SOLV
Solventum Corp
|
74.78 | 12.92B | 8.26B | 66.00M | 1.17B | 0.3682 |
|
DOCS
Doximity Inc
|
58.26 | 10.88B | 516.85M | 174.11M | 217.38M | 0.87 |
|
TEM
Tempus Ai Inc
|
64.99 | 10.23B | 640.44M | -743.28M | -206.93M | -11.29 |
|
HQY
Healthequity Inc
|
112.07 | 9.71B | 1.15B | 96.70M | -161.99M | 1.09 |
Aclarion Inc Stock (ACON) Latest News
Major Clinical Breakthrough: Leading Medical Center Tests Revolutionary AI-Powered Spine Surgery Technology - StockTitan
Stocks of Aclarion Inc (ACON) are poised to climb above their peers - SETE News
Aclarion secures funding for pivotal CLARITY trial By Investing.com - Investing.com South Africa
Aclarion, Inc. (ACON) Showcases AI-Powered NOCISCAN for Chronic Back Pain Diagnosis at Selby Spine Conference - MSN
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Aclarion Announces CLARITY Trial for Nociscan Now Fully Funded - OrthoSpineNews
12 AI News and Ratings You Should Not Miss - Insider Monkey
Understanding ACON stock ratios for better investment decisions - US Post News
What's Going On With Aclarion Stock Tuesday? - Benzinga
Investor Confidence Grows As Aclarion (ACON) Secures Funding For CLARITY Trial - Stocks Telegraph
Aclarion secures funding for pivotal CLARITY trial - Investing.com
Riding the Waves: A Guide to Investing in ACON Stock - The InvestChronicle
NOCISCAN touted as lumbar pain diagnostic advance - MSN
Aclarion, Inc. Enters into Securities Purchase Agreement for Registered Direct Offering - Defense World
Aclarion’s Retail Following Jumps 60% After Reverse Stock Split As Micro-Cap Health Tech Shares Nearly Double - MSN
Aclarion to Showcase Groundbreaking NOCISCAN Technology at the Selby Spine Conference - OrthoSpineNews
NOCISCAN touted as lumbar pain diagnostic advance By Investing.com - Investing.com UK
Aclarion, Inc. Announces Securities Purchase Agreement - TipRanks
Aclarion announces reverse stock split effective January 29 - MSN
Aclarion announces reverse stock split effective January 29 By Investing.com - Investing.com Australia
Aclarion Announces $4.7 Million Registered Direct Stock Offering - citybuzz -
Aclarion Announces Pricing of Registered Direct Offering of Common Stock Priced at the Market - Yahoo Finance
Stock market news: Aclarion plunged by 99.50% while Foxx Development surged by 221.11% during mid day trading - Business Upturn
Stock market today: Aclarion -99.69%, CARGO Therapeutics -76.31% among biggest losers in early trading - Business Upturn
Stock market today: Aclarion plunged by 99.72% while Crown Electrokinetics was down by 99.52% in early trading - Business Upturn
Aclarion Takes Bold Step: Executes 1-for-370 Reverse Stock Split to Boost Market Position - The Africa Logistics
Aclarion Announces Updated Product Release That Expands Mri Scanner Access for Nociscan Solution - Marketscreener.com
Aclarion, Inc. Announces First Commercial Agreement in Michigan -August 14, 2024 at 08:08 am EDT - Marketscreener.com
Aclarion, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 - Marketscreener.com
Aclarion, Inc. George Frey MD as Key Opinion Leader -January 17, 2023 at 08:29 am EST - Marketscreener.com
Aclarion, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 - Marketscreener.com
Aclarion, Inc. announced that it has received $1 million in funding -September 29, 2024 - Marketscreener.com
Aclarion Launches Surgeon Partnership to Apply Nociscan's Ai Technology to Personal Injury and Workers Compensation Market - Marketscreener.com
Aclarion's Nociscan AI Plays Key Role in Advanced Understanding of Modic Changes - Marketscreener.com
Stock market news: Aclarion plunged by 99.74% while Signing Day Sports surged by 125.77% during mid day trading - Business Upturn
Stock market today: Aclarion declined by 99.74% while Ocean Biomedical surged by 27.94% in early trading - Business Upturn
Aclarion stock plunges to 52-week low, touches $0.03 - MSN
Aclarion announces revised reverse stock split details By Investing.com - Investing.com South Africa
Aclarion stock plunges to 52-week low, touches $0.03 By Investing.com - Investing.com South Africa
Aclarion announces revised reverse stock split details - MSN
Aclarion Announces Revised Split Ratio and Timing for Reverse Stock Split - Yahoo Finance
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Aclarion Inc Stock (ACON) Financials Data
Revenue
Net Income
Cash Flow
EPS
8.82%
3.54%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):